Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects.

Gilbert ES, Curtis RE, Hauptmann M, Kleinerman RA, Lynch CF, Stovall M, Smith SA, Weathers R, Andersson M, Dores GM, Fraumeni JF Jr, Fossa SD, Hall P, Hodgson DC, Holowaty EJ, Joensuu H, Johannesen TB, Langmark F, Kaijser M, Pukkala E, Rajaraman P, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Aleman BM, Travis LB, Morton LM, van Leeuwen FE.

Radiat Res. 2017 Feb;187(2):186-195. doi: 10.1667/RR14453.1. Epub 2017 Jan 24.

PMID:
28118119
2.

Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting.

Gierach GL, Curtis RE, Pfeiffer RM, Mullooly M, Ntowe EA, Hoover RN, Nyante SJ, Feigelson HS, Glass AG, Berrington de Gonzalez A.

JAMA Oncol. 2016 Oct 6. doi: 10.1001/jamaoncol.2016.3340. [Epub ahead of print]

PMID:
27711920
3.

Increased pancreatic cancer risk following radiotherapy for testicular cancer.

Hauptmann M, Børge Johannesen T, Gilbert ES, Stovall M, van Leeuwen FE, Rajaraman P, Smith SA, Weathers RE, Aleman BM, Andersson M, Curtis RE, Dores GM, Fraumeni JF Jr, Hall P, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Lynch CF, Pukkala E, Storm HH, Vaalavirta L, van den Belt-Dusebout AW, Morton LM, Fossa SD, Travis LB.

Br J Cancer. 2016 Sep 27;115(7):901-8. doi: 10.1038/bjc.2016.272. Epub 2016 Sep 6.

PMID:
27599043
4.

Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12.

Srour SA, Devesa SS, Morton LM, Check DP, Curtis RE, Linet MS, Dores GM.

Br J Haematol. 2016 Aug;174(3):382-96. doi: 10.1111/bjh.14061. Epub 2016 Apr 7. Erratum in: Br J Haematol. 2017 Apr;177(2):331.

PMID:
27061824
5.

Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.

Lam CJ, Curtis RE, Dores GM, Engels EA, Caporaso NE, Polliack A, Warren JL, Young HA, Levine PH, Elmi AF, Fraumeni JF Jr, Tucker MA, Morton LM.

J Clin Oncol. 2015 Oct 1;33(28):3096-104. doi: 10.1200/JCO.2014.60.2094. Epub 2015 Aug 3.

6.

Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers.

Shiels MS, Gibson T, Sampson J, Albanes D, Andreotti G, Beane Freeman L, Berrington de Gonzalez A, Caporaso N, Curtis RE, Elena J, Freedman ND, Robien K, Black A, Morton LM.

J Clin Oncol. 2014 Dec 10;32(35):3989-95. doi: 10.1200/JCO.2014.56.8220. Epub 2014 Nov 10.

7.

Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma.

Morton LM, Gilbert ES, Stovall M, van Leeuwen FE, Dores GM, Lynch CF, Hall P, Smith SA, Weathers RE, Storm HH, Hodgson DC, Kleinerman RA, Joensuu H, Johannesen TB, Andersson M, Holowaty EJ, Kaijser M, Pukkala E, Vaalavirta L, Fossa SD, Langmark F, Travis LB, Lamart S, Simon SL, Fraumeni JF Jr, Aleman BM, Curtis RE.

Haematologica. 2014 Oct;99(10):e193-6. doi: 10.3324/haematol.2014.108258. No abstract available.

8.

Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies.

Gibson TM, Park Y, Robien K, Shiels MS, Black A, Sampson JN, Purdue MP, Freeman LE, Andreotti G, Weinstein SJ, Albanes D, Fraumeni JF Jr, Curtis RE, Berrington de Gonzalez A, Morton LM.

J Clin Oncol. 2014 Dec 10;32(35):4004-11. doi: 10.1200/JCO.2014.56.8444. Epub 2014 Sep 29.

9.

The rising incidence of second cancers: patterns of occurrence and identification of risk factors for children and adults.

Morton LM, Onel K, Curtis RE, Hungate EA, Armstrong GT.

Am Soc Clin Oncol Educ Book. 2014:e57-67. doi: 10.14694/EdBook_AM.2014.34.e57. Review.

10.

Pooling prospective studies to investigate the etiology of second cancers.

Black A, Gibson TM, Shiels MS, Park Y, Robien K, Albanes D, Weinstein SJ, Freeman LE, Andreotti G, Purdue MP, Fraumeni JF, Hartge P, Tucker MA, Hoover RN, Cerhan JR, Zeleniuch-Jacquotte A, Curtis RE, Elena J, Sampson JN, Berrington de Gonzalez A, Morton LM.

Cancer Epidemiol Biomarkers Prev. 2014 Aug;23(8):1598-608. doi: 10.1158/1055-9965.EPI-14-0191. Epub 2014 May 15.

11.

Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program.

Kutsenko A, Berrington de Gonzalez A, Curtis RE, Rajaraman P.

Cancer Causes Control. 2014 Jun;25(6):659-68. doi: 10.1007/s10552-014-0367-5. Epub 2014 Mar 30.

PMID:
24682745
12.

Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site.

Khalil MO, Morton LM, Devesa SS, Check DP, Curtis RE, Weisenburger DD, Dores GM.

Br J Haematol. 2014 Apr;165(1):67-77. doi: 10.1111/bjh.12730. Epub 2014 Jan 12.

13.

Prediction of the location and size of the stomach using patient characteristics for retrospective radiation dose estimation following radiotherapy.

Lamart S, Imran R, Simon SL, Doi K, Morton LM, Curtis RE, Lee C, Drozdovitch V, Maass-Moreno R, Chen CC, Whatley M, Miller DL, Pacak K, Lee C.

Phys Med Biol. 2013 Dec 21;58(24):8739-53. doi: 10.1088/0031-9155/58/24/8739. Epub 2013 Dec 4.

14.

Stomach cancer risk after treatment for hodgkin lymphoma.

Morton LM, Dores GM, Curtis RE, Lynch CF, Stovall M, Hall P, Gilbert ES, Hodgson DC, Storm HH, Johannesen TB, Smith SA, Weathers RE, Andersson M, Fossa SD, Hauptmann M, Holowaty EJ, Joensuu H, Kaijser M, Kleinerman RA, Langmark F, Pukkala E, Vaalavirta L, van den Belt-Dusebout AW, Fraumeni JF Jr, Travis LB, Aleman BM, van Leeuwen FE.

J Clin Oncol. 2013 Sep 20;31(27):3369-77. doi: 10.1200/JCO.2013.50.6832. Epub 2013 Aug 26.

15.

Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer.

Kleinerman RA, Smith SA, Holowaty E, Hall P, Pukkala E, Vaalavirta L, Stovall M, Weathers R, Gilbert E, Aleman BM, Kaijser M, Andersson M, Storm H, Joensuu H, Lynch CF, Dores GM, Travis LB, Morton LM, Curtis RE.

Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):922-9. doi: 10.1016/j.ijrobp.2013.04.010. Epub 2013 May 22.

16.

Radiation dose to the esophagus from breast cancer radiation therapy, 1943-1996: an international population-based study of 414 patients.

Lamart S, Stovall M, Simon SL, Smith SA, Weathers RE, Howell RM, Curtis RE, Aleman BM, Travis L, Kwon D, Morton LM.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):694-701. doi: 10.1016/j.ijrobp.2013.03.014. Epub 2013 Apr 26.

PMID:
23628135
17.

Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.

Morton LM, Dores GM, Tucker MA, Kim CJ, Onel K, Gilbert ES, Fraumeni JF Jr, Curtis RE.

Blood. 2013 Apr 11;121(15):2996-3004. doi: 10.1182/blood-2012-08-448068. Epub 2013 Feb 14.

18.

Risk of non-Hodgkin lymphoma after radiotherapy for solid cancers.

Kim CJ, Freedman DM, Curtis RE, Berrington de Gonzalez A, Morton LM.

Leuk Lymphoma. 2013 Aug;54(8):1691-7. doi: 10.3109/10428194.2012.753543. Epub 2012 Dec 31.

19.

The association between cancer and amyotrophic lateral sclerosis.

Freedman DM, Curtis RE, Daugherty SE, Goedert JJ, Kuncl RW, Tucker MA.

Cancer Causes Control. 2013 Jan;24(1):55-60. doi: 10.1007/s10552-012-0089-5. Epub 2012 Oct 23.

20.

Patterns of bone sarcomas as a second malignancy in relation to radiotherapy in adulthood and histologic type.

Wu LC, Kleinerman RA, Curtis RE, Savage SA, de González AB.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):1993-9. doi: 10.1158/1055-9965.EPI-12-0810. Epub 2012 Sep 10.

Supplemental Content

Loading ...
Support Center